BackgroundCheck.run
Search For

Kyle Lee Atkinson, 571800 S Ann Blvd, Harker Heights, TX 76548

Known as:
Kyle L Atkinson Kyle Lee Mcleod Kyle L Atinkson Kyle N
Related to:
Mickey Sue Mcleod 76

Kyle Atkinson Phones & Addresses

Harker Heights, TX   

16605 Ray Cir, Alvin, TX 77511   

Loveland, CO   

7951 Pontiac St, Commerce City, CO 80022    303-2879202   

Lakewood, CO   

Westminster, CO   

Salem, OR   

Pensacola, FL   

Frisco, CO   

1166 Madison Ave LOT 62, Loveland, CO 80537    720-3946949   

Education

Degree: High school graduate or higher
Get Report
Control this profile

Mentions for Kyle Lee Atkinson

Kyle Atkinson resumes & CV records

Resumes

Kyle Atkinson Photo 43

Kyle Atkinson

Kyle Atkinson Photo 44

Kyle Atkinson

Kyle Atkinson Photo 45

Kyle Atkinson

Kyle Atkinson Photo 46

Kyle Atkinson

Kyle Atkinson Photo 47

Kyle Atkinson

Location:
United States
Kyle Atkinson Photo 48

President At Financial Forecast Center, Llc

Location:
Houston, Texas Area
Industry:
Financial Services

Publications & IP owners

Us Patents

Compositions Containing, Methods Involving, And Uses Of Non-Natural Amino Acid Linked Dolastatin Derivatives

US Patent:
2022041, Dec 29, 2022
Filed:
Apr 28, 2022
Appl. No.:
17/732285
Inventors:
- La Jolla CA, US
Kyle ATKINSON - Golden CO, US
Sandra BIROC - Alameda CA, US
Timothy BUSS - Carlsbad CA, US
Melissa NEAL - Vista CA, US
Vadim KRAYNOV - San Diego CA, US
Robin MARSDEN - San Diego CA, US
Jason PINKSTAFF - San Rafael CA, US
Lillian SKIDMORE - San Diego CA, US
Ying SUN - San Diego CA, US
Agnieszka SZYDLIK - San Francisco CA, US
Delia Ianina LOPEZ DE VALENTA - Poway CA, US
Assignee:
Ambrx, Inc. - La Jolla CA
International Classification:
C07K 5/103
C07D 207/08
C07D 401/12
C07D 417/12
C07K 5/02
A61K 47/68
A61K 38/07
Abstract:
Disclosed herein are non-natural amino acids and dolastatin analogs that include at least one non-natural amino acid, and methods for making such non-natural amino acids and polypeptides. The dolastatin analogs can include a wide range of possible functionalities, but typically have at least one oxime, carbonyl, dicarbonyl, and/or hydroxylamine group. Also disclosed herein are non-natural amino acid dolastatin analogs that are further modified post-translationally, methods for effecting such modifications, and methods for purifying such dolastatin analogs. Typically, the modified dolastatin analogs include at least one oxime, carbonyl, dicarbonyl, and/or hydroxylamine group. Further disclosed are methods for using such non-natural amino acid dolastatin analogs and modified non-natural amino acid dolastatin analogs, including therapeutic, diagnostic, and other biotechnology use.

Compositions Containing, Methods Involving, And Uses Of Non-Natural Amino Acid Linked Dolastatin Derivatives

US Patent:
2021027, Sep 9, 2021
Filed:
Jan 5, 2021
Appl. No.:
17/142169
Inventors:
- La Jolla CA, US
Kyle ATKINSON - Golden CO, US
Sandra BIROC - Alameda CA, US
Timothy BUSS - Carlsbad CA, US
Melissa NEAL - Vista CA, US
Vadim KRAYNOV - San Diego CA, US
Robin MARSDEN - San Diego CA, US
Jason PINKSTAFF - San Rafael CA, US
Lillian SKIDMORE - San Diego CA, US
Ying SUN - San Diego CA, US
Agnieszka SZYDLIK - San Francisco CA, US
Delia Ianina LOPEZ DE VALENTA - Poway CA, US
Assignee:
Ambrx, Inc. - La Jolla CA
International Classification:
C07K 5/103
C07D 207/08
C07D 401/12
C07D 417/12
C07K 5/02
A61K 47/68
A61K 38/07
Abstract:
Disclosed herein are non-natural amino acids and dolastatin analogs that include at least one non-natural amino acid, and methods for making such non-natural amino acids and polypeptides. The dolastatin analogs can include a wide range of possible functionalities, but typically have at least one oxime, carbonyl, dicarbonyl, and/or hydroxylamine group. Also disclosed herein are non-natural amino acid dolastatin analogs that are further modified post-translationally, methods for effecting such modifications, and methods for purifying such dolastatin analogs. Typically, the modified dolastatin analogs include at least one oxime, carbonyl, dicarbonyl, and/or hydroxylamine group. Further disclosed are methods for using such non-natural amino acid dolastatin analogs and modified non-natural amino acid dolastatin analogs, including therapeutic, diagnostic, and other biotechnology use.

Compositions Containing, Methods Involving, And Uses Of Non-Natural Amino Acid Linked Dolastatin Derivatives

US Patent:
2018000, Jan 11, 2018
Filed:
Sep 12, 2017
Appl. No.:
15/702682
Inventors:
- La Jolla CA, US
Kyle Atkinson - Golden CO, US
Sandra Biroc - Alameda CA, US
Timothy Buss - Carlsbad CA, US
Melissa Neal - Vista CA, US
Vadim Kraynov - San Diego CA, US
Robin Marsden - San Diego CA, US
Jaosn Pinkstaff - San Rafael CA, US
Lillian Skidmore - San Diego CA, US
Ying Sun - San Diego CA, US
Agnieszka Szydlik - San Francisco CA, US
Delia Lanina Lopez De Valenta - Poway CA, US
Assignee:
Ambrx, Inc. - La Jolla CA
International Classification:
C07K 5/103
C07K 5/02
C07D 401/12
C07D 207/08
A61K 38/07
C07D 417/12
C07K 5/062
Abstract:
Disclosed herein are non-natural amino acids and dolastatin analogs that include at least one non-natural amino acid, and methods for making such non-natural amino acids and polypeptides. The dolastatin analogs can include a wide range of possible functionalities, but typically have at least one oxime, carbonyl, dicarbonyl, and/or hydroxylamine group. Also disclosed herein are non-natural amino acid dolastatin analogs that are further modified post-translationally, methods for effecting such modifications, and methods for purifying such dolastatin analogs. Typically, the modified dolastatin analogs include at least one oxime, carbonyl, dicarbonyl, and/or hydroxylamine group. Further disclosed are methods for using such non-natural amino acid dolastatin analogs and modified non-natural amino acid dolastatin analogs, including therapeutic, diagnostic, and other biotechnology use.

Compositions Containing, Methods Involving, And Uses Of Non-Natural Amino Acid Linked Dolastatin Derivatives

US Patent:
2016005, Feb 25, 2016
Filed:
May 24, 2012
Appl. No.:
14/122672
Inventors:
- La Jolla CA, US
Kyle Atkinson - Golden CO, US
Sandra Biroc - Alameda CA, US
Timothy Buss - Carlsbad CA, US
Melissa Neal - Vista CA, US
Vadim Kraynov - San Diego CA, US
Robin Marsden - San Diego CA, US
Jason Pinkstaff - Encinitas CA, US
Lillian Skidmore - San Diego CA, US
Ying Sun - San Diego CA, US
Assignee:
AMBRX, INC. - La Jolla CA
International Classification:
C07K 5/103
A61K 47/48
A61K 38/07
Abstract:
Disclosed herein are non-natural amino acids and dolastatin analogs that include at least one non-natural amino acid, and methods for making such non-natural amino acids and polypeptides. The dolastatin analogs can include a wide range of possible functionalities, but typically have at least one oxime, carbonyl, dicarbonyl, and/or hydroxylamine group. Also disclosed herein are non-natural amino acid dolastatin analogs that are further modified post-translationally, methods for effecting such modifications, and methods for purifying such dolastatin analogs. Typically, the modified dolastatin analogs include at least one oxime, carbonyl, dicarbonyl, and/or hydroxylamine group. Further disclosed are methods for using such non-natural amino acid dolastatin analogs and modified non-natural amino acid dolastatin analogs, including therapeutic, diagnostic, and other biotechnology use.

Modified Animal Erythropoietin Polypeptides And Their Uses

US Patent:
2016002, Jan 28, 2016
Filed:
Sep 15, 2015
Appl. No.:
14/854819
Inventors:
- La Jolla CA, US
- Indianapolis IN, US
Frank SONG - San Diego CA, US
Stephanie CHU - Simi Valley CA, US
Joseph SHEFFER - Cardiff CA, US
Richard S. BARNETT - San Marcos CA, US
Marc SILADI - San Diego CA, US
Kyle ATKINSON - Golden CO, US
Darin LEE - San Diego CA, US
Peter C. CANNING - Indianapolis IN, US
International Classification:
C07K 14/505
A61K 47/48
A61K 38/18
Abstract:
Modified animal erythropoietin polypeptides and uses thereof are provided.

Compositions Containing, Methods Involving, And Uses Of Non-Natural Amino Acid Linked Dolastatin Derivatives

US Patent:
2015008, Mar 19, 2015
Filed:
May 24, 2012
Appl. No.:
14/122667
Inventors:
- La Jolla CA, US
Kyle Atkinson - Golden CO, US
Sandra Biroc - Alameda CA, US
Timothy Buss - Carlsbad CA, US
Melissa Neal - Vista CA, US
Vadim Kraynov - San Diego CA, US
Robin Mardsen - San Diego CA, US
Jason Pinkstaff - San Rafael CA, US
Lillian Skidmore - San Diego CA, US
Ying Sun - San Diego CA, US
Agnieszka Szydlik - San Francisco CA, US
Ianina Valenta - Poway CA, US
Assignee:
AMBRX, INC. - La Jolla CA
International Classification:
C07K 5/06
C07K 16/28
A61K 47/48
US Classification:
5303919, 548204, 548540, 5462791
Abstract:
Disclosed herein are non-natural amino acids and dolastatin analogs that include at least one non-natural amino acid, and methods for making such non-natural amino acids and polypeptides. The dolastatin analogs can include a wide range of possible functionalities, but typically have at least one oxime, carbonyl, dicarbonyl, and/or hydroxylamine group. Also disclosed herein are non-natural amino acid dolastatin analogs that are further modified post-translationally, methods for effecting such modifications, and methods for purifying such dolastatin analogs. Typically, the modified dolastatin analogs include at least one oxime, carbonyl, dicarbonyl, and/or hydroxylamine group. Further disclosed are methods for using such non-natural amino acid dolastatin analogs and modified non-natural amino acid dolastatin analogs, including therapeutic, diagnostic, and other biotechnology uses.

Possible Relatives

David A Atkinson  Dawn M Atkinson  Dean Atkinson  Deanna D Atkinson  Daisie D Atkinson  Dallin D Atkinson  Damian E Atkinson  Kyle Johnson  Kyle J Johnston  Kyle R Stanek 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.